|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 810 | - | - | 188 | 23.2 | 187 | 23.1 | 386 | 47.7 | 49 | 6.0 |
| 2015-2019 | 818 | 1 | 0.1 | 172 | 21.0 | 186 | 22.7 | 404 | 49.4 | 55 | 6.7 |
| 2014-2018 | 808 | 1 | 0.1 | 159 | 19.7 | 197 | 24.4 | 393 | 48.6 | 58 | 7.2 |
| 2013-2017 | 753 | 1 | 0.1 | 133 | 17.7 | 184 | 24.4 | 382 | 50.7 | 53 | 7.0 |
| 2012-2016 | 738 | 1 | 0.1 | 119 | 16.1 | 180 | 24.4 | 379 | 51.4 | 59 | 8.0 |
| 2011-2015 | 727 | 1 | 0.1 | 122 | 16.8 | 175 | 24.1 | 368 | 50.6 | 61 | 8.4 |
| 2010-2014 | 729 | - | - | 127 | 17.4 | 172 | 23.6 | 360 | 49.4 | 70 | 9.6 |
| 2009-2013 | 728 | - | - | 124 | 17.0 | 154 | 21.2 | 371 | 51.0 | 79 | 10.9 |
| 2008-2012 | 752 | - | - | 136 | 18.1 | 137 | 18.2 | 384 | 51.1 | 95 | 12.6 |
| 2007-2011 | 767 | 1 | 0.1 | 134 | 17.5 | 133 | 17.3 | 385 | 50.2 | 114 | 14.9 |
| 2006-2010 | 755 | 1 | 0.1 | 126 | 16.7 | 126 | 16.7 | 392 | 51.9 | 110 | 14.6 |
| 2005-2009 | 744 | 1 | 0.1 | 130 | 17.5 | 131 | 17.6 | 384 | 51.6 | 98 | 13.2 |
| 2004-2008 | 742 | 1 | 0.1 | 128 | 17.3 | 143 | 19.3 | 373 | 50.3 | 97 | 13.1 |
| 2003-2007 | 753 | 1 | 0.1 | 125 | 16.6 | 168 | 22.3 | 346 | 45.9 | 113 | 15.0 |
| 2002-2006 | 717 | - | - | 132 | 18.4 | 165 | 23.0 | 324 | 45.2 | 96 | 13.4 |
| 2001-2005 | 729 | 1 | 0.1 | 140 | 19.2 | 166 | 22.8 | 297 | 40.7 | 125 | 17.1 |
| 2000-2004 | 737 | 1 | 0.1 | 134 | 18.2 | 173 | 23.5 | 284 | 38.5 | 145 | 19.7 |
| 1999-2003 | 738 | 1 | 0.1 | 143 | 19.4 | 174 | 23.6 | 269 | 36.4 | 151 | 20.5 |
| 1998-2002 | 730 | 1 | 0.1 | 162 | 22.2 | 167 | 22.9 | 269 | 36.8 | 131 | 17.9 |
| 1997-2001 | 736 | 1 | 0.1 | 159 | 21.6 | 175 | 23.8 | 263 | 35.7 | 138 | 18.8 |
| 1996-2000 | 729 | - | - | 157 | 21.5 | 180 | 24.7 | 261 | 35.8 | 131 | 18.0 |
| 1995-1999 | 717 | - | - | 147 | 20.5 | 178 | 24.8 | 254 | 35.4 | 138 | 19.2 |
| 1994-1998 | 725 | - | - | 144 | 19.9 | 196 | 27.0 | 232 | 32.0 | 153 | 21.1 |
| 1993-1997 | 732 | - | - | 138 | 18.9 | 190 | 26.0 | 226 | 30.9 | 178 | 24.3 |
| 1992-1996 | 735 | - | - | 141 | 19.2 | 185 | 25.2 | 216 | 29.4 | 193 | 26.3 |
| 1991-1995 | 731 | 1 | 0.1 | 137 | 18.7 | 187 | 25.6 | 204 | 27.9 | 202 | 27.6 |
| 1990-1994 | 735 | 1 | 0.1 | 132 | 18.0 | 185 | 25.2 | 204 | 27.8 | 213 | 29.0 |
| 1989-1993 | 698 | 2 | 0.3 | 125 | 17.9 | 161 | 23.1 | 190 | 27.2 | 220 | 31.5 |
| 1988-1992 | 680 | 2 | 0.3 | 105 | 15.4 | 167 | 24.6 | 192 | 28.2 | 214 | 31.5 |
| 1987-1991 | 626 | 2 | 0.3 | 102 | 16.3 | 152 | 24.3 | 178 | 28.4 | 192 | 30.7 |
| 1986-1990 | 586 | 1 | 0.2 | 107 | 18.3 | 140 | 23.9 | 170 | 29.0 | 168 | 28.7 |
| 1985-1989 | 539 | 1 | 0.2 | 118 | 21.9 | 124 | 23.0 | 157 | 29.1 | 139 | 25.8 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |